You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study

Article info

Article menu

Download PDFPDF

Rheumatoid arthritis
Extended report
Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study

Authors

  • Wei Zhang Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Nick Bansback Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Huiying Sun Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  • Ronald Pedersen Pfizer Inc., Collegeville, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Sameer Kotak Pfizer Inc., Collegeville, Pennsylvania, USA PubMed articlesGoogle scholar articles
  • Aslam H Anis Centre for Health Evaluation and Outcome Sciences, St Paul's Hospital, Vancouver, British Columbia, Canada School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Aslam H Anis; aslam.anis{at}ubc.ca
View Full Text

Citation

Zhang W, Bansback N, Sun H, et al
Estimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE study
RMD Open 2015;1:e000042. doi: 10.1136/rmdopen-2014-000042

Publication history

  • Received December 23, 2014
  • Revision received February 24, 2015
  • Accepted March 5, 2015
  • First published April 8, 2015.
Online issue publication 
October 26, 2017

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/